Login/Sign Up
₹13950
(Inclusive of all Taxes)
₹11096 with coupons & bank offers*
Get Free delivery (₹99) with
Tishtha 40 mg Injection 4 ml is a prescription immunotherapy medicine used to treat several types of advanced cancers, including melanoma, non-small cell lung cancer, kidney cancer, bladder cancer, head and neck cancer, and classical Hodgkin lymphoma. It works by helping your body's immune system recognise and attack cancer cells more effectively, slowing disease progression and improving treatment outcomes in eligible patients.
This medicine is administered as an intravenous (IV) infusion by a trained healthcare professional in a hospital or infusion centre. Depending on your condition and treatment plan, it is usually given every 2, 3, or 4 weeks. It is important to attend every scheduled appointment and complete your treatment as recommended by your doctor.
Your healthcare team will monitor you regularly throughout treatment with blood tests and clinical assessments. Unlike chemotherapy, Tishtha 40 mg Injection 4 ml stimulates the immune system, which can sometimes cause it to attack healthy organs. Contact your doctor immediately if you develop persistent diarrhoea, severe abdominal pain, a new or worsening cough, shortness of breath, yellowing of the skin or eyes, severe skin rash, vision changes, or unusual fatigue.
Before starting treatment, tell your doctor if you have an autoimmune disease, have received an organ transplant, or have lung, liver, kidney, or thyroid problems. Inform your healthcare provider about all medicines, herbal products, and dietary supplements you are taking before beginning treatment.
This medicine may harm an unborn baby. Women should use effective contraception during treatment and for at least 5 months after the last dose. Breastfeeding is not recommended during treatment and for at least 5 months after the final dose. Older adults generally tolerate this medicine similarly to younger adults but may require closer monitoring depending on their overall health.
Your doctor may prescribe this medicine to help manage the following conditions:
When used as prescribed, Tishtha 40 mg Injection 4 ml offers several important benefits in the treatment of advanced cancers.
Consult your doctor
It is unknown whether Tishtha 40 mg Injection 4 ml interacts with alcohol. Consult your doctor for more information.
Unsafe
Tishtha 40 mg Injection 4 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Tishtha 40 mg Injection 4 ml. You should not become pregnant while you are receiving Tishtha 40 mg Injection 4 ml for at least five months from the last dose of Tishtha 40 mg Injection 4 ml. Using effective birth control methods while on treatment is suggested.
Unsafe
Tishtha 40 mg Injection 4 ml should not be taken if you are breastfeeding as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine and for at least five months from the last dose of medicine.
Not applicable
Tishtha 40 mg Injection 4 ml will be administered to hospitalized patients.
Caution
If you have a pre-existing or a history of liver problems, tell your doctor before receiving this medicine. Inform your doctor if you experience severe nausea or vomiting, right-sided upper stomach pain, easy bruising or bleeding, dark urine, or jaundice (yellowing of the skin or eyes). Your doctor may suggest tests to monitor your liver function while on treatment with this medicine.
Caution
If you have a pre-existing or a history of kidney diseases, inform your doctor before receiving Tishtha 40 mg Injection 4 ml. Tell your doctor if you have little or no urination, swelling in your feet or ankles, or blood in your urine. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Safe if prescribed
Tishtha 40 mg Injection 4 ml is not recommended for children below 12 years. It is safe for use in children above 12 years for the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer. It will be administered only if the benefits outweigh the risks.
Consult your doctor
Please consult your doctor before receiving Tishtha 40 mg Injection 4 ml if you have pre-existing heart problems. Your doctor will prescribe Tishtha 40 mg Injection 4 ml if the benefits outweigh the risks.
Consult your doctor
Please consult a doctor before administering Tishtha 40 mg Injection 4 ml to geriatric patients. Your doctor will prescribe Tishtha 40 mg Injection 4 ml if the benefits outweigh the risks.
Have a query?
The time required for Tishtha 40 mg Injection 4 ml to start to work: The time required for Tishtha 40 mg Injection 4 ml to show its action is not clinically established. The time for which the effects of Tishtha 40 mg Injection 4 ml last: The duration of action for Tishtha 40 mg Injection 4 ml is not clinically established.
Keep Refrigerated. Do not freeze.
Login/Sign Up
Login/Sign Up
Disclaimer
